Cannonau (CNNC) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 41 106 sessions, October 29, 2025 to October 29, 2026
- Largest daily move
- +500% close of November 21, 2025
- 1-year change
- -50% closing prices, October 29, 2025 to October 29, 2026
- 1-month change
- +100% closing prices, September 25, 2026 to October 29, 2026
Company Description
Cannonau (OTC: CNNC) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $48.3K.
CNNC has declined 50.0% over the past year. The last closing price was $0.0002.
For FY2023, Cannonau reported net income of $338K.
This page collects what Stock Titan holds for CNNC, including price data, latest news, and financial highlights.
Stock Performance
Cannonau (CNNC) closed at $0.0002 on October 29, 2026. Over the past 12 months, the price has lost 50.0%.
CNNC Metrics & Rankings
Price returns through October 29, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Cannonau has 8 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 0 with negative movement. View all CNNC news →
SEC Filings
Financial Highlights
Cannonau reported operating income of -$30K in FY2023, and net income was $338K. The company generated -$32K in operating cash flow.
Upcoming Events
CNNC Company Profile & Sector Positioning
Cannonau (CNNC) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CNNC often look at related companies in the same sector, including Cryomass Technologies Inc (CRYM), Instadose Pharma Corp (INSD), Hero Technologies Inc (HENC), Emergent Health Corp (EMGE), and Endexx Corp (EDXC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CNNC's relative position within its industry.